<DOC>
	<DOCNO>NCT02846454</DOCNO>
	<brief_summary>This propose randomized , double blind 12 week crossover human feeding study aim investigate effect consume composite drink inulin arabinoxylan satiety measure appetite biomarkers subjective satiety , energy/food intake change human gut microbiota healthy weight male ( 22 24.9kg/m2 )</brief_summary>
	<brief_title>Effects Inulin Arabinoxylan Satiety , Energy/Food Intake Changes Human Gut Microbiota</brief_title>
	<detailed_description>Research focus mechanism involve appetite regulation topical give emergence worldwide obesity epidemic . Understanding physiological process associate onset obesity essential development effective anti-obesity strategy . There evidence people consume diet high non-starch polysaccharide ( NSPs ) low body mass index ( BMI ) . A 2009 review fibre satiety Bridget Benelam , 2009 focus different type fibre significant impact may satiety and/or energy intake , fermentation fibre non starch polysaccharide colon gut bacterial group Bifidobacterium . non starch polysaccharide fibre source poorly digest human enzyme small intestine degrade large group bacteria large bowel . One beneficial outcome fermentation fibre gut bacteria produce metabolite call short chain fatty acid ( SCFA ) think affect appetite regulation stimulate production satiety hormone help feel full . Acetate propionate two metabolite highlight potential mediator satiety . Some fibre call prebiotics act selective source beneficial gut bacteria . However Western population consume natural prebiotics high quantity diet overall intake fibre also low . Therefore , study , investigator aim utilise mixture prebiotics order increase growth and/or activity commensal gut bacteria SCFA production human volunteer assess effect consumption satiety . Testing impact composite mix inulin arabinoxylan human study help determine effect appetite regulation , ad libitum food intake , SCFA production , anthropometric measurement , cognitive state ( e.g . mood ) composition gut microbiota . The study design 12 week randomize , human feeding study , crossover design test composite mix inulin arabinoxylan equivalent energy match ( kcal ) maltodextrin control drink 33 healthy weight ( 22 24.9kg/m2 ) male age 21-55 . Volunteers enrol treatment placebo four week , four week wash crossover . primary endpoint , satiety follow test meal challenge measure four occasion throughout study . Anthropometry measure , dietary intake , body weight blood pressure monitor throughout study . Faecal urine collect baseline end treatment period .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>Males 2155 year old Body Mass Index ( BMI ) 19.524.5kg/m2 Overall healthy Weight Stable ( &lt; 3 kg change past 4 month , trial ) . Smokers drink 28 unit alcohol per week ( i.e . 14 pint beer 28 small glass wine ) Restricted diet weight loss , vegetarian/vegan take dietary supplement prebiotics ( oligosaccharide ie Fructooligosaccharides ( FOS ) , galactooligosaccharides ( GOS ) probiotic ( ie Actimel ) ) , eat breakfast &gt; 25g/d dietary fibre consumption well food allergy Gastrointestinal procedure surgery past three month . Gastrointestinal disorder : celiac disease , Intestinal Bowel Disease ( IBD ) , irritable bowel syndrome ( IBS ) , chronic constipation , diverticulitis history chronic constipation , diarrhoea , chronic gastrointestinal complaint Disorders swallow , severe dysphagia food pill . Appetite modulator drug : orlistat , sibutramine , rimonabant . Mood disorder medication : antidepressant , lithium . Chronic metabolic condition : diabetes , hepatic disease , gout , kidney , thyroid coagulation disease . Psychiatric disorder : severe depression , bulimia , anorexia , schizophrenia , bipolar disorder . Pregnancy Others : oral antidiabetic , insulin , digoxin , thyroid hormone , antibiotic , steroid immunosuppressant , recreational substance . Use implant portable electromechanical device cardiac peacemaker infusion pump . Blood donor past 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>